Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy
Journal of Clinical and Experimental Hematopathology · 2024
DOI: 10.3960/jslrt.24009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Yu Yagi und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
- Department of Pharmacy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
- Department of Radiation Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
- Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Zitieren
APA
Yagi, Y., Kanemasa, Y., Sasaki, Y., Goto, S., Yamamura, Y., Masuda, Y., Fujita, K., Ishimine, K., Hayashi, Y., Mino, M., Ohigashi, A., Morita, Y., Tamura, T., Nakamura, S., Okuya, T., Matsuda, S., Shimizuguchi, T., Shingai, N., Toya, T., …, & Shimoyama, T. (2024). Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24009
Vancouver
Yagi Y, Kanemasa Y, Sasaki Y, Goto S, Yamamura Y, Masuda Y, et al. Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24009
BibTeX
@article{Yagi2024,
author = {Yagi, Yu and Kanemasa, Yusuke and Sasaki, Yuki and Goto, Sotaro and Yamamura, Yasuhiko and Masuda, Yusuke and Fujita, Kumiko and Ishimine, Kento and Hayashi, Yudai and Mino, Mano and Ohigashi, An and Morita, Yuka and Tamura, Taichi and Nakamura, Shohei and Okuya, Toshihiro and Matsuda, Shinichiro and Shimizuguchi, Takuya and Shingai, Naoki and Toya, Takashi and Shimizu, Hiroaki and Najima, Yuho and Kobayashi, Takeshi and Haraguchi, Kyoko and Doki, Noriko and Okuyama, Yoshiki and Shimoyama, Tatsu},
title = {Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2024},
doi = {10.3960/jslrt.24009}
}
EUVIMED